D.E. Shaw & Co
ARIA

D.E. Shaw & Co’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

D.E. Shaw & Co’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-65,062
Closed -$809K – 3797
2016
Q4 		$809K Buy
65,062
+9,990
+18% +$120K ﹤0.01% 2583
2016
Q3 		$754K Buy
55,072
+43,129
+361% +$433K ﹤0.01% 2573
2016
Q2 		$88K Sell
11,943
-1,093,055
-99% -$8.2M ﹤0.01% 3268
2016
Q1 		$7.06M Sell
1,104,998
-68,633
-6% -$385K 0.01% 1059
2015
Q4 		$7.33M Buy
1,173,631
+1,017,660
+652% +$6.68M 0.01% 1158
2015
Q3 		$911K Sell
155,971
-25,438
-14% -$196K ﹤0.01% 2659
2015
Q2 		$1.5M Sell
181,409
-47,924
-21% -$424K ﹤0.01% 2415
2015
Q1 		$1.89M Sell
229,333
-136,195
-37% -$1.01M ﹤0.01% 2056
2014
Q4 		$2.51M Buy
365,528
+283,028
+343% +$1.77M ﹤0.01% 2094
2014
Q3 		$446K Sell
82,500
-353,653
-81% -$2.07M ﹤0.01% 3440
2014
Q2 		$2.78M Buy
436,153
+76,547
+21% +$526K ﹤0.01% 2046
2014
Q1 		$2.9M Buy
359,606
+334,137
+1,312% +$2.6M ﹤0.01% 2027
2013
Q4 		$174K Sell
25,469
-9,543
-27% -$51.5K ﹤0.01% 4295
2013
Q3 		$644K Buy
35,012
+21,074
+151% +$409K ﹤0.01% 3390
2013
Q2 		$244K Buy
+13,938
New +$247K ﹤0.01% 3679

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

D.E. Shaw & Co's ARIA Position: Q1 2017 in Review

D.E. Shaw & Co sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 65,062 shares — an estimated $809K sold.

D.E. Shaw & Co first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $7.33M in Q4 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • D.E. Shaw & Co reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 65,062 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $809K.
  • D.E. Shaw & Co first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • D.E. Shaw & Co's Ariad Pharmaceuticals Inc position peaked at $7.33M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on D.E. Shaw & Co's 13F filing for Q1 2017, filed 15 May 2017.